Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals

Science

TOKYO (Reuters) – Japanese biopharmaceutical firm Anges Inc said on Tuesday it and partner Osaka University had completed development of a prophylactic DNA vaccine against the new coronavirus and that it would begin testing it in animals soon.

Shares of Anges were untraded with a glut of buy orders in early morning.

There are now more than 350,000 cases of coronavirus infections globally and over 15,000 deaths resulting from the disease it causes, called COVID-19.

Reporting by Chang-Ran Kim; Editing by Kim Coghill

Products You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *